Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.
Crypto and stablecoin adoption, board roles in AI and ASC 740 disclosure requirements are topics in Weaver’s Accounting & SEC Update: Q3 2025 summary.
Weaver helps a health system evaluate its revenue quality, estimate collections and gain clarity on complex streams.
Drive stronger board discussions at organizations with key questions on cyber risk, AI oversight, crisis planning, M&A outlook and tax law changes.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
Our Health Care Valuation Insights Hub is your go-to resource for knowledge and strategies to stay ahead in an evolving industry.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
In our recent feature in BOSS Magazine, Weaver's Morgan Page shares why staying aligned with the purpose behind technology is just as important as the tools themselves.
The DOJ’s updated compliance guidelines require proactive AI risk management. Take steps to ensure your company meets the standards.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
Explore how to apply the IIA’s AI Auditing Framework with practical tips and a risk-based lens. Assess and govern AI risk in any organization.
See how ambulatory surgery centers (ASC) and imaging center valuation multiples compare, revealing key differences, patterns and transaction risk.